feed info

10 articles from ScienceDaily

Data from Israel: myocarditis after COVID-19 vaccines remain rare, highest risk in young males

An examination of data of people who received the Pfizer-BioNTech COVID-19 vaccine in Israel found males 14 to 30 years of age were the most susceptible to myocarditis after a second or third dose of the Pfizer-BioNTech COVID-19 vaccine, however, the overall risk remains relatively low. Among males ages 16 to 19 years, approximately 1 in 15,000 developed myocarditis after a booster dose of the...

Stem cell-gene therapy shows promise in ALS safety trial

Investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis, a fatal neurological disorder known as ALS or Lou Gehrig's disease.